Heptakis(6-O-tert-butyldimethylsilyl)-β-cyclodextrin Tetradecaacetate (CAS 123172-94-1)

Heptakis(6-O-tert-butyldimethylsilyl)-β-cyclodextrin Tetradecaacetate is a chemically modified cyclodextrin extensively used in scientific research, particularly for studies on molecular encapsulation and stabilization. This derivative of β-cyclodextrin, where each glucose unit′s primary hydroxyl group is protected by a tert-butyldimethylsilyl group and the secondary hydroxyl groups are acetylated, is pivotal in enhancing the solubility and thermal stability of encapsulated guest molecules. The modification increases the molecule′s ability to form host-guest complexes with a variety of organic compounds, making it a useful tool in the study of supramolecular chemistry. Researchers utilize this compound to investigate the dynamics of molecular encapsulation, which has significant implications for understanding how small molecules are stabilized and released in various conditions. This is crucial for the advancement of technologies in materials science and nano-delivery systems. The chemical′s unique structure allows for detailed studies on the effects of encapsulation on the physicochemical properties of guest molecules, such as volatility and reactivity. In the context of supramolecular research, Heptakis(6-O-tert-butyldimethylsilyl)-β-cyclodextrin Tetradecaacetate serves as a model compound to explore the principles of molecular recognition and binding affinity. This facilitates a deeper understanding of the molecular interactions that underpin the formation and stability of cyclodextrin-based complexes, crucial for developing more efficient and selective encapsulation systems.